Efficacy and Safety of Lumateperone for Treatment of Schizophrenia
273 Citations•2020•
Christoph U. Correll, Robert E. Davis, Michal Weingart
This randomized clinical trial examines the efficacy and safety of lumateperone for the short-term treatment of adults with schizophrenia.
Abstract
ClinicalTrials.gov identifier: NCT02282761.